Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/5960
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLouck, Lauren E-
dc.contributor.authorCara, Kelly C-
dc.contributor.authorKlatt, Kevin-
dc.contributor.authorWallace, Taylor C-
dc.contributor.authorChung, Mei-
dc.date.accessioned2024-09-21T01:38:16Z-
dc.date.available2024-09-21T01:38:16Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/5960-
dc.description.abstractCholine is essential for proper liver, muscle, brain, lipid metabolism, cellular membrane composition, and repair. Understanding genetic determinants of circulating choline metabolites can help identify new determinants of choline metabolism, requirements, and their link to disease endpoints. We conducted a scoping review to identify studies assessing the association of genetic polymorphisms on circulating choline and choline-related metabolite concentrations and subsequent associations with health outcomes. This study follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement scoping review extension. Literature was searched to September 28, 2022, in 4 databases: Embase, MEDLINE, Web of Science, and the Biological Science Index. Studies of any duration in humans were considered. Any genome-wide association study (GWAS) investigating genetic variant associations with circulating choline and/or cholinerelated metabolites and any Mendelian randomization (MR) study investigating the association of genetically predicted circulating choline and/or choline-related metabolites with any health outcome were considered. Qualitative evidence is presented in summary tables. From 1248 total reviewed articles, 53 were included (GWAS ¼ 27; MR ¼ 26). Forty-two circulating choline-related metabolites were tested in association with genetic variants in GWAS studies, primarily trimethylamine N-oxide, betaine, sphingomyelins, lysophosphatidylcholines, and phosphatidylcholines. MR studies investigated associations between 52 total unique choline metabolites and 66 unique health outcomes. Of these, 47 significant associations were reported between 16 metabolites (primarily choline, lysophosphatidylcholines, phosphatidylcholines, betaine, and sphingomyelins) and 27 health outcomes including cancer, cardiovascular, metabolic, bone, and brainrelated outcomes. Some articles reported significant associations between multiple choline types and the same health outcome. Genetically predicted circulating choline and choline-related metabolite concentrations are associated with a wide variety of health outcomes. Further research is needed to assess how genetic variability influences choline metabolism and whether individuals with lower genetically predicted circulating choline and choline-related metabolite concentrations would benefit from a dietary intervention or supplementation.en_US
dc.language.isoen_USen_US
dc.publisherAdvances in Nutritionen_US
dc.relation.ispartofseriesReview;100164-
dc.subjectcholineen_US
dc.subjectglycerophosphocholineen_US
dc.subjectlysophosphatidylcholinesen_US
dc.subjectphosphatidylcholinesen_US
dc.subjectsphingomyelinsen_US
dc.subjectbetaineen_US
dc.subjecttrimethylamine N-oxideen_US
dc.subjectMendelian randomizationen_US
dc.subjectgenome-wide association studyen_US
dc.subjectscoping reviewen_US
dc.titleThe Relationship of Circulating Choline and Choline-Related Metabolite Levels with Health Outcomes: A Scoping Review of Genome-Wide Association Studies and Mendelian Randomization Studiesen_US
dc.typeArticleen_US
Appears in Collections:VOL 15 NO 2 (2024)

Files in This Item:
File Description SizeFormat 
4. The-Relationship-of-Circulating-Choline-and-Cholin.pdf100164618.94 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.